Medical Weight Loss for Gulfport, Mississippi Residents

Gulfport, Mississippi residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Gulfport through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Flexible payment for Gulfport residents: we accept HSA, FSA, Klarna, and Affirm, so paying for your Mississippi telehealth program can fit your budget. Medication is billed separately. Doctor review just $119 (medication separate).

Why Gulfport Residents Choose New Hope Weight Loss

We made New Hope easy to start without making it less serious. A Gulfport patient can go from first visit to a physician-approved plan without insurance paperwork, prior authorizations, or a single drive to an office. The $119 review with Dr. Anjmun Sharma is flat, the medication price is published, and the whole thing happens by telehealth. Low friction to begin, real medicine once you do, the same standard everyone in Mississippi gets.

Gulfport is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Gulfport patients at home.

New Hope Weight Loss is based in Costa Mesa, yet a patient in Gulfport sees the same doctor, takes the same approach, and pays the same prices, all through telehealth across Mississippi. We care for patients throughout Downtown, the beachfront, and the greater Mississippi Gulf Coast. Follow-up check-ins are handled remotely, so adjusting your dose is simple whether you live near downtown Gulfport or out toward Downtown, the beachfront, and the greater Mississippi Gulf Coast.

Whether you live in central Gulfport or out toward the edges of Mississippi, you see the same physician, Dr. Anjmun Sharma, and pay the same flat pricing with no distance surcharge. The 90-day semaglutide program is $499, which works out to a lower monthly cost than paying month to month for many Gulfport patients. New Hope Weight Loss serves patients across Mississippi entirely by telehealth from our Costa Mesa, California clinic, so the same physician care reaches every part of the state.

GLP-1 Weight Loss Programs Available

Semaglutide: the 90-Day Metabolic Reset

If you live in Gulfport and want a clear starting point, this is it. Semaglutide, the active ingredient also used in Wegovy and Ozempic, costs from $166 per month or $499 for the 90-day program. Branded-drug trials showed roughly 15 to 17 percent average weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, so results vary.

Tirzepatide: the dual GLP-1 and GIP option

For patients who want a second lever, tirzepatide starts at $233 per month and acts on both GLP-1 and GIP receptors. Up to 22.5 percent body-weight loss appeared in branded-drug trials at qualifying doses, which is not typical. It shares an active ingredient with Mounjaro and Zepbound.

A $119 physician review is required up front. Medication billed separately. HSA, FSA, Klarna, and Affirm are accepted.

How Telehealth Works for Gulfport

Step 1. Complete the online intake and weight-history quiz from your phone or laptop.

Step 2. Dr. Sharma reviews everything and meets you over secure video, typically within 48 hours, to confirm whether compounded semaglutide or tirzepatide makes sense for you.

Step 3. If appropriate, a state-licensed 503(a) pharmacy ships your medication to your Gulfport home in insulated cold-pack packaging.

Step 4. You check in by video for follow-ups, so adjusting your dose never means a drive across .

Frequently Asked Questions, Gulfport

I live in Gulfport. Is the nearest New Hope Weight Loss office close by?

The nearest office is in Costa Mesa, California, which is our only physical site. That said, you do not have to be near it. We treat Gulfport, Mississippi patients by telehealth, and a video consult with Dr. Anjmun Sharma confirms whether you are a candidate for compounded semaglutide or tirzepatide.

Will I ever need to show up in person if I am in Gulfport?

No in-person visits are needed for Gulfport residents. The entire program is telehealth, from your first consult to refills and check-ins. When you qualify, your medication ships to Gulfport in cold-pack packaging designed to maintain the proper temperature throughout shipping.

What are the prices for Gulfport residents?

A physician review costs $119. Compounded semaglutide is priced from $166 per month or $499 for a 90-day course, and tirzepatide from $233 per month. Medication is charged on its own. Payment through HSA, FSA, Klarna, or Affirm is accepted, and we never add a distance surcharge for Gulfport.

What areas of Gulfport do you serve?

We serve patients from across Gulfport by telehealth, including Downtown, the beachfront, and the greater Mississippi Gulf Coast.

How does compounded medication compare on cost for Gulfport patients?

Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Gulfport patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.

Gulfport Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Gulfport, Mississippi by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.